Show simple item record

dc.contributor.authorLi, Hui(Sun Yat Sen Univ, Sch Life Sci)
dc.contributor.authorYe, Ming-Zhi(Sun Yat Sen Univ, Sch Life Sci)
dc.contributor.authorWu, Hong-Kai(Sun Yat Sen Univ, Sch Life Sci)
dc.contributor.authorXiong, Xiao-Peng(Sun Yat Sen Univ, Sch Life Sci)
dc.contributor.authorWang, Chao(Sun Yat Sen Univ, Sch Life Sci)
dc.contributor.authorPeng, Xuan-Xian(Sun Yat Sen Univ, Sch Life Sci)
dc.contributor.authorPeng, Bo
dc.contributor.authorXu, Chang-Xin
dc.contributor.authorWang, San-Ying
dc.contributor.author王三英
dc.date.accessioned2011-07-22T02:05:36Z
dc.date.available2011-07-22T02:05:36Z
dc.date.issued2010
dc.identifier.citationJ. Proteome Res., 2010, 9 (5), pp 2573–2583zh_CN
dc.identifier.issn1535-3893
dc.identifier.urihttp://dx.doi.org/doi:10.1021/pr1000219
dc.identifier.urihttps://dspace.xmu.edu.cn/handle/2288/10243
dc.description.abstractBacterium is still a major cause of many infectious diseases and a global threat to human health, aquaculture, and animal feeding. Prevention by vaccination is the most efficient and economical way of fighting bacterial diseases, but one of the persistent challenges to prevent bacterial infections and disease transmissions is the existence of multiple bacterial species, families, and genera and the lack of efficient polyvalent vaccines against them. The information on candidate immunogens for polyvalent vaccine development is elusive, as well. For the development of broad cross-protective vaccines, we have employed heterogeneous antiserum-based immunoproteomics approaches to identify antigenically similar outer membrane (OM) proteins that could be used as potential polyvalent vaccine candidates against Vibrio parahaemolyticus, V. alginolyticus, V. fluvialis, Aeromonas hydrophila, and A. sobria infections. VPA1435, VP0764, VPA1186, VP1061, and VP2850 could be recognized by at least three antisera and demonstrated significantly passive and active immune protection against V. parahaemolyticus infection in a crucian carp model. VP1061 and VP2850 induced higher immune and protective abilities than the other three OM proteins. Furthermore, the abilities of VP1061 and VP2850 in the generation of broad cross-protective immune reaction against the infections of V. alginolyticus, A. hydrophila, and Pseudomonas fluorescens were also investigated in fish and mouse models. Our results suggested that VP1061 and VP2850 could potentially be used as polyvalent vaccine candidates for the development of novel polyvalent vaccines against V. parahaemolyticus and other Gram-negative pathogens. On the basis of these results, characteristics of OM proteins as polyvalent vaccine candidates have been addressed.zh_CN
dc.description.sponsorship973 project [2006CB101807]; NSFC [30530610, 40876076]; foundation of Guangdong for Natural Sciences [7117645]zh_CN
dc.language.isoenzh_CN
dc.publisherAMER CHEMICAL SOCzh_CN
dc.subjectpolyvalent vaccinezh_CN
dc.subjectV. parahaemolyticuszh_CN
dc.subjectimmunoproteomicszh_CN
dc.subjectcross-protective immunogenszh_CN
dc.subjectouter membrane proteinszh_CN
dc.subjectVP1061zh_CN
dc.subjectVP2850zh_CN
dc.titleImmunoproteomic Identification of Polyvalent Vaccine Candidates from Vibrio parahaemolyticus Outer Membrane Proteinszh_CN
dc.typeArticlezh_CN


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record